No Detail Found!

Dynamic Evolution of SARS-CoV-2 in West Sumatra: analyzing s gene mutations across variants and their impact on publichealth and vaccine strategies

Author(s)
Linosefa Linosefa Faculty of Medicine, Universitas Andalas, Padang, Indonesia; Department of Microbiology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia; Center for Infectious Disease Diagnostic and Research, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
Hasmiwati Department of Parasitology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
Jamsari Jamsari Department of Biotechnology, Universitas Andalas, Padang, Indonesia
Andani Eka Putra Department of Microbiology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia; Center for Infectious Disease Diagnostic and Research, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
Abstract
Background and Objective: The global SARS-CoV-2 pandemic highlights the importance of tracking virus evolution through genomic surveillance, especially concerning mutations in the SARS-CoV-2 spike protein, crucial for vaccine development. Despite global concern over variants, regions like West Sumatra, Indonesia, lack thorough genomic analysis, prompting this studyto analyze S gene mutations across three pandemic waves in West Sumatra. Materialasnd Methods: Next-generation sequencinwgas conducted through the lllumina MiSeq instrument to leverage a dataset of 352 anonymized samples collected between March, 2020 and November, 2022 and rigorous analysis of S gene mutation using CLC Genomics Workbench® 21 version 21.0.3 were employed. Statistical analyses assessed mutation prevalence over time, exploring associations with clinical outcomes. Results: The findings revealed significant variability in mutation profilesacross different variants. Notablyt,h e Omicron variant (21K) exhibited ahigh mutation rate, suggesting enhancedimmune evasion capabilities. Comparative analysis highlighted evolutionary trends, from early variants with fewer mutations to highly adapted forms like Delta(211) and OmicronT.he dynamic nature of SARS-CoV-2 evolution underscoresthe importance of continuoussurveillance, rapid public health response and vaccine adaptation. Conclusion: This study contributes valuable insights into the virus's evolving landscape, emphasizing the need for ongoing research, global collaboration and adaptable vaccine strategies to manage the evolving threat of COVID-19 effectively.
Publication Details
Page(s) 182-189
Published Journal: Pakistan Journal of Biological Sciences, Volume: 27, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
SARS-CoV-2, viral evolution, spike gene mutations, genomic surveillance, West Sumatra
References
Raghwani J,McCrone S.C. .2022 .Genomic epidemiology of early SARS-CoV-2 transmission dynamics. , : .
Infect Emerg. . .. , 28 : 751-758.
Zhang G.,Zeng H.,Pan C.,Li Y.,Hu Y. .2020 .. , : .
. .Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: A randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect. Dis., 21 : 181-192.
Malik J.A,Ahmed S.,Mir A.,Shinde M.,Bender O. .2022 .The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.. , : .
Infect J. . .. , 15 : 228-240.
Brito AF,Kalinich C.C. .2022 .Global disparities in SARS-CoV-2 genomic surveillance. Nat. Commun, 13(10) : 541467.
Saravanan KA,Panigrahi M.,Kumar H.,Rajawat D.,Nayak S.S.,Bhushan B.,Dutt T. .2022 .Role of genomics in combating COVID-19 pandemic. , 823 : .
.2022 .. , 146387 : .
Hodcroft EB,Zuber M.,Nadeau S.,Vaughan and KH.D. T.G. .2021 .Spread of a SARS-CoV-2 variant through Europein the summer of 2020. , 595 : 707-712.
Greaney AJ,Binshtein E. .2021 .Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe, 29 : 44-57.
Liu Y.,J. Rockl6v Y. .2021 .The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. J. Travel Med, 28 : .
. .. , : .
Plante J.A,Xia H.,Johnson B.A. .2021 .. , : .
. .Spike mutation D614G alters SARS-CoV-2 fitness. Nature, 592 : 116-121.
Harvey ,A.M. Carabelli B,Jackson RK .2021 .SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol., 19 : 409-424.
Alpert T.,M.E. Petrone etal T. .2021 .Multiplex gPCR discriminvaatrieansts of concern to enhance global surveillance of SARS-CoV-2. , 3001236 : .
He D.,Chen B.,Zhao S.,Stone L. .2023 .The immune evasion ability of Delta variant is comparabl eto that of Beta variant in South Africa. BMC Public Health, 23 : .
Li H.,Song J.,Rahmati M.,Park S. .2023 .. , : .
. .Genetics, structure, transmission, epidemiology, immune response, and vaccine efficacies of the SARS-CoV-2 Delta variant: A comprehensive review. Rev. Med, 33 : .
. .. , : .
Chan KC,Song Y.,Xu Z.,Shang C.,Zhou R. .2022 .. , : .
. .SARS-CoV-2 Delta variant: Interplay between individual mutatianod ntsheir allosteric synergy. Biomolecules, 12 : .
. .. , : .
Zabidi N.Z,Farouk A. .2023 .Evolution of SARS-CoV-2 variants: Implicationsonimmune escape, vaccination, therapeutic and diagnostic strategies. Viruses, 15 : .
Dubey A,Kumar P.,Tomar S. .2022 .. , : .
Emerging . .2 variants: Genetic variability and clinical ~ implications. , 79 : .
McCormick KD .2021 .. JL. Jacobs and JW. Mellors, : .
. .The emerging plasticity of SARS-CoV-2: The evolution of SARS-CoV-2 poses challenges for vaccines and immunotherapies. Science, 371 : 1306-1308.
Chowdhury S.,Chowdhury S.,Chowdhury M.S.,Chowdhury N.S. .2021 .Current review of Delta variant of SARS-CoV-2. J. Med. Health Sci, 3 : 23-29.
Gupta P,Singh CM.,Singhal L. .2023 .. , : .
. .. Emergence of COVID-19 variants: An update. Cureus, 15 : .
. .. , : .
Gerardi V.,Atasoy M.O.,Munir M. .2023 .Deep structural analysis of myriads of omicron sub-variants revealed hotspot for vaccine escape immunity. Vaccines, 11 : .
Kumar A,Asghar A.,Singh H.N.,Faiqand S.Kumar M.A. .2023 .SARS-CoV-2 omicron variant genomic sequences and their epidemiological correlates regarding the end of the pandemic: /n silico analysis. MIR Bioinf. Biotech., 4 : .
Krammer F. .2020 .SARS-CoV-2 vaccines in development.. , : .
Nature . .. , 586 : 516-527.
Hatcher EL,Zhdanov SA,Bao Y.,Blinkova O.,Nawrocki E.P. .2017 .Virus variation resource-improved response to emergent viral outbreaks. Nucleic Acids Res, 45 : D482-D490.
0

Citations

0

Downloads

22

Views